Literature DB >> 12201577

Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region.

Erika Martins Braga1, Rosa Maria Barros, Tânia Afonso Reis, Cor Jesus F Fontes, Cristiane Guimarães Morais, Maria Sĵnia Martins, Antoniana Ursine Krettli.   

Abstract

The antibody response to the C-terminal 19-kD fragment of Plasmodium falciparum merozoite surface protein-1 (PfMSP1-19) was investigated in groups of subjects living in areas of Brazil with different levels of malaria transmission. The prevalence and the levels of IgG to PfMSP1-19 increased with the time of exposure and were positively correlated with the absence of clinical symptoms in parasitemic patients. The frequency of positive response and the mean level of IgG were higher in areas where malaria prevalence was more intense, especially among asymptomatic patients. The serum absorbance values of the IgG1 isotype were significantly higher among subjects with long-term exposure and in asymptomatic infections. These data suggest a protective role of IgG1 in naturally acquired immunity in spite of the unstable transmission levels in the Brazilian Amazon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12201577     DOI: 10.4269/ajtmh.2002.66.461

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.

Authors:  Paulo Afonso Nogueira; Fabiana Piovesan Alves; Carmen Fernandez-Becerra; Oliver Pein; Neida Rodrigues Santos; Luiz Hildebrando Pereira da Silva; Erney Plessman Camargo; Hernando A del Portillo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Malaria in Brazil: an overview.

Authors:  Joseli Oliveira-Ferreira; Marcus V G Lacerda; Patrícia Brasil; José L B Ladislau; Pedro L Tauil; Cláudio Tadeu Daniel-Ribeiro
Journal:  Malar J       Date:  2010-04-30       Impact factor: 2.979

3.  Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.

Authors:  Danielle I Stanisic; Freya J I Fowkes; Melanie Koinari; Sarah Javati; Enmoore Lin; Benson Kiniboro; Jack S Richards; Leanne J Robinson; Louis Schofield; James W Kazura; Christopher L King; Peter Zimmerman; Ingrid Felger; Peter M Siba; Ivo Mueller; James G Beeson
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

4.  IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil.

Authors:  Cristiane G Morais; Irene S Soares; Luzia H Carvalho; Cor Jesus F Fontes; Antoniana U Krettli; Erika Martins Braga
Journal:  Parasitol Res       Date:  2005-03-10       Impact factor: 2.289

5.  Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies.

Authors:  Charlotte Joos; Laurence Marrama; Hannah E J Polson; Sandra Corre; Antoine-Marie Diatta; Babacar Diouf; Jean-François Trape; Adama Tall; Shirley Longacre; Ronald Perraut
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

6.  Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.

Authors:  Danielle I Stanisic; Jack S Richards; Fiona J McCallum; Pascal Michon; Christopher L King; Sonja Schoepflin; Paul R Gilson; Vincent J Murphy; Robin F Anders; Ivo Mueller; James G Beeson
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

7.  Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.

Authors:  J C Lima-Junior; T M Tran; E V S Meyer; B Singh; S G De-Simone; F Santos; C T Daniel-Ribeiro; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

8.  Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection.

Authors:  Christian M F Okafor; Chiaka I Anumudu; Yusuf O Omosun; Chairat Uthaipibull; Idowu Ayede; Henrietta O Awobode; Alex B Odaibo; Jean Langhorne; Anthony A Holder; Roseangela I Nwuba; Marita Troye-Blomberg
Journal:  Malar J       Date:  2009-11-23       Impact factor: 2.979

9.  The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria.

Authors:  David Courtin; Mayke Oesterholt; Harm Huismans; Kwadwo Kusi; Jacqueline Milet; Cyril Badaut; Oumar Gaye; Will Roeffen; Edmond J Remarque; Robert Sauerwein; André Garcia; Adrian J F Luty
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

10.  Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon.

Authors:  Bruno Bezerril Andrade; Bruno Coelho Rocha; Antonio Reis-Filho; Luís Marcelo Aranha Camargo; Wanderli Pedro Tadei; Luciano Andrade Moreira; Aldina Barral; Manoel Barral-Netto
Journal:  Malar J       Date:  2009-06-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.